Qi Yu Chen is a Chinese businessperson who has been at the head of 24 different companies and currently is Chairman for China Medical Pharmaceutical Material Association, Chairman at Beijing Xingyuan Innovative Equity Investment Fund Mgmt Co, Chairman at Shanghai Fosun Pioneering Investment Mgmt Ltd., Chairman of Shanghai Xingshuangjian Medical Investment Mgmt Co., Ltd., Chairman at Fosun Industrial Co., Ltd., Chairman at Shanghai Fusheng Pharmaceutical Technology Dev Co., Ltd., Chairman for Shanghai Fosun Chemical Pharm Venture Capital Co. Ltd., Chairman for Shanghai Fosun Venture Capital Investment Management Co., Ltd., Co-Chairman of New Frontier Health Corp., Co-Chief Executive Officer & Executive Director at Fosun International Ltd. and President of Fosun Atlas Capital Management LLC. Mr. Chen is also Chairman for Shanghai Fosun High Technology (Group) Co., Ltd., Chairman of Shanghai Biopharmaceutical Industry Association and Vice Chief Commissioner at China Medicinal Biotech Association and on the board of 51 other companies.

Qi Yu Chen previously occupied the position of Chairman for Shanghai Fosun Pharmaceutical Co. Ltd., Chairman of Neng Yue Co., Ltd., Vice Chairman at Shanghai Licensed Pharmacist Association and Chairman of Shanghai Pharmaceutical Industry Association.

He received an undergraduate degree from Fudan University and an MBA from China Europe International Business School.